Thermo Fisher Scientific(US:TMO) 仪器信息网·2025-06-14 03:48Group 1 - The core viewpoint of the article is that Thermo Fisher Scientific is selling part of its diagnostic business for approximately $4 billion (about 287.24 billion RMB) to optimize its asset portfolio and divest from underperforming business segments [1][4]. - The company has engaged financial advisors to seek private equity investors for the sale of its diagnostic business, which includes the microbiology department that produces infectious disease testing equipment [4]. - There is no guarantee that the asset sale will be completed, and Thermo Fisher Scientific may ultimately decide to retain the asset [4]. Group 2 - Earlier in February, the company completed the acquisition of Solventum's purification and filtration business for $4.1 billion in cash [4].